Connecting to LinkedIn...

Blank

SEC Pharma appoints three Associate Directors to support growth plans in 2013

SEC Pharma appoints three Associate Directors to support growth plans in 2013

SEC Pharma, the European pharmaceutical recruitment consultancy, has just appointed three Associate Directors to drive the growth of its specialist recruitment services.  With over 25 years’ recruiting experience between them, Louis Gicquel, James Carrera and James Brown were all previously consultants and, most recently, team leaders at SEC. They have all been promoted to the role of Associate Director as a result of their consistently high levels of delivery, depth of understanding of their markets and their team leadership abilities.

James Carerra will manage the planned growth for Biometrics, Health Economics/Outcomes Research, Market Access, Marketing, Medical Communications and Healthcare. Louis Giquel will do the same for Clinical Development, Clinical Operations, Business Development, Clinical Outsourcing and Medical Affairs, while James Brown will focus on Regulatory/QA, Drug Safety, Manufacturing and R&D.

These new positions are the latest in a series of enhancements to SEC’s management structure and have been created in order to take advantage of growth opportunities throughout Europe within the Pharma and IT sectors during 2013 and beyond.

Stuart Britton, CEO of SEC Recruitment said “I am delighted to announce these appointments as  James, Louis and James have all worked with SEC for more than five years, and have demonstrated through hard work and results that they are talented professionals who can play an important part in our future.  All of them joined as trainees or junior consultants and their appointments demonstrate that we nurture, train, encourage and grow our talented people at SEC.”

Tags:

Articles similar to

Articles similar to